Why the Immuron (ASX:IMC) share price is rocketing up 10% today

The Immuron Ltd (ASX: IMC) share price is surging today following a research agreement with Monash University for combating COVID-19. At the time of writing, the Immuron share price is up 10.42% to 26.5 cents.

Immuron is clinical-stage biopharmaceutical company focused on the development and commercialisation of a novel class of specifically targeted polyclonal antibodies. The company researches and develops hyperimmune products for markets in Australia, the United States and Canada.

Product sales comprise Travelan and Protectyn, which is used for the prevention of travellers’ diarrhoea.

What’s pushing the Immuron share price higher?

The Immuron share price has been a positive mover today compared to the broader All Ordinaries…